Olivier Bron, who leads Bloomingdale’s - a division of Macy’s Inc - disclosed a sale of Macy’s common stock amounting to 3,051 shares on March 30, 2026, a transaction reported on a Form 4 filed with the Securities and Exchange Commission. The shares sold at a weighted average price of $17.7424, producing total proceeds of $54,132. Traded prices for the lot ranged between $17.5500 and $17.8850.
The transaction followed an exercise on March 28 in which Bron acquired 7,504 shares as a result of restricted stock units vesting. Those shares were obtained at a price of $0, reflecting their status as RSUs converted into common stock upon vesting.
After these movements, Bron's direct ownership in Macy’s stands at 15,672 shares. At the time of the sale, Macy’s common stock was trading at $18.10. The share price is 19% lower on a year-to-date basis, while it has appreciated 46% over the past 12 months.
Valuation snapshot
InvestingPro data cited in the filing note that Macy’s trades at a price-to-earnings ratio of 7.8 and yields a dividend of 4.36% at current levels. Those metrics are presented alongside the insider transaction but do not change the documented details of Bron’s holdings or the sale proceeds.
Recent financial performance and analyst responses
Macy’s reported fourth-quarter 2025 adjusted diluted earnings per share of $1.67, above a consensus forecast of $1.56. Revenue for the quarter came in at $7.6 billion versus an expected $7.46 billion.
Following the results, Jefferies maintained a Buy rating on Macy’s stock with a $22.00 price target. The firm’s stance was issued despite Macy’s fiscal 2026 guidance coming in below Wall Street estimates; the company attributed that guidance shortfall to accounting changes and store closures.
Other firms adjusted their targets in different directions. TD Cowen lowered its price target to $20 from $21, noting a 6% earnings beat and a 1.8% rise in comparable sales driven by strength in fragrance and luxury categories. Telsey reduced its target to $20 from $25 while highlighting better-than-expected sales, gross margin, and operating expense outcomes. Evercore ISI trimmed its target to $19 from $21, citing valuation concerns even as Macy’s same-store sales and EBIT margin exceeded expectations.
Context and implications
The transactions reported by Bron consist of a modest sale following the conversion of RSUs into shares. The sale amount and resulting ownership position are disclosed in regulatory filings, while recent operating results and analyst target changes provide the market backdrop against which the insider activity occurred.
As disclosed, the company’s most recent quarter outperformed expectations on both EPS and revenue, but guidance and accounting-related factors have led to mixed analyst reactions and target adjustments. The information here is limited to the transactions, current ownership, valuation metrics, quarterly results, and subsequent analyst actions as stated in the filing and related notes.